TY  - BOOK
AU  - Abraha,Iosief
AU  - Cusi,Cristina
ED  - Cochrane Collaboration.
TI  - Alcohol and drug misuse
T2  - Cochrane handbook
SN  - 9781118454473
AV  - RC564.15 
U1  - 616.86/06 23
PY  - 2013///
CY  - Chichester, West Sussex
PB  - John Wiley & Sons
KW  - Drug abuse
KW  - Treatment
KW  - Alcoholism
KW  - Substance-Related Disorders
KW  - therapy
KW  - Comparative Effectiveness Research
KW  - Early Medical Intervention
KW  - Social Support
KW  - SELF-HELP
KW  - Substance Abuse & Addictions
KW  - Drug Dependence
KW  - bisacsh
KW  - General
KW  - Twelve-Step Programs
KW  - fast
KW  - Review
KW  - Electronic books
N1  - Includes bibliographical references and index; Part 1. Alcohol. Psychosocial interventions -- Effectiveness of brief alcohol interventions in primary care populations -- Brief interventions for heavy alcohol users admitted to general hospital wards -- Alcoholics Anonymous and other 12-step programmes for alcohol dependence -- Mentoring adolescents to prevent substance use disorders -- Universal school-based prevention programmes for alcohol misuse in young people -- Universal multicomponent prevention programmes for alcohol misuse in young people -- Universal family-based prevention programmes for alcohol misuse in young people -- Social norms interventions to reduce alcohol misuse in university or college students -- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy -- Pharmacological interventions -- Benzodiazepines for alcohol withdrawal -- Anticonvulsants for alcohol withdrawal -- Acamprosate for alcohol dependence -- Baclofen for alcohol withdrawal -- Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse -- Psychotropic analgesic nitrous oxide for alcohol withdrawal -- Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal -- Opioid antagonists for alcohol dependence -- Pharmacologic interventions for pregnant women enrolled in alcohol treatment; Part 2. Drugs. Psychosocial interventions -- School-based prevention for illicit substance use disorders -- Interventions for prevention of substance use disorders by young people delivered in non-school settings -- Case management for persons with substance use disorders -- Motivational interviewing for substance use disorders -- Therapeutic communities for substance use disorders -- Interventions for drug-using offenders in the courts, secure estabishments and the community -- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions -- Cocaine dependence -- Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders -- Antidepressants for cocaine dependence -- Antipsychotic medications for cocaine dependence -- Anticonvulsants for cocaine dependence -- Dopamine agonists for cocaine dependence -- Disulfiram for the treatment of cocaine dependence -- Efficacy of psychostimulant drugs for cocaine dependence -- Auricular acupuncture for cocaine dependence -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence -- Methadone at tapered doses for the management of opioid withdrawal -- Methadone maintenance at different dosages for opioid dependence -- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence -- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal -- Opioid antagonists with minimal sedation for opioid withdrawal -- Oral naltrexone maintenance treatment for opioid dependence -- Sustained-release naltrexone for opioid dependence -- Heroin maintenance for chronic heroin-dependent individuals -- LAAM maintainance verus methadone maintenance for heroin dependence -- Detoxification treatments for opiate-dependent adolescents -- Maintenance treatments for opiate-dependent adolescents -- Maintenance agonist treatment for opiate-dependent adolescents -- Maintenance agonist treatments for opiate-dependent pregnant women -- Pharmacological treatments for depression during opoid dependence -- Inpatient versus other setttings for detoxification for opiod dependence -- Psychotherapeutic interventions for cannabis use or dependence in outpatient settings -- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings -- Treatment for amphetamine dependence -- Treatment for amphetamine withdrawal -- Treatment for amphetamine psychosis -- Treatment for methaqualone dependence in adults; gm
UR  - http://dx.doi.org/10.1002/9781118454503
ER  -